Acute phase protein
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Acute-phase proteins are a class of proteins whose plasma concentrations increase (positive acute phase proteins) or decrease (negative acute phase proteins) in response to inflammation. This response is called the acute-phase reaction (also called acute phase response).
In response to injury, local inflammatory cells (neutrophil granulocytes and macrophages) secrete a number of cytokines into the bloodstream, most notable of which are the interleukins IL-1, IL-6 and IL-8, and TNF-α.
The liver responds by producing a large number of acute-phase reactants.
Examples
The notable are:
- D-dimer protein
- C-reactive protein
- Mannose-binding protein
- Alpha 1-antitrypsin
- Alpha 1-antichymotrypsin
- Alpha 2-macroglobulin
- some coagulation factors (Fibrinogen, prothrombin, factor VIII, von Willebrand factor, plasminogen)
- Complement factors
- Ferritin
- Serum amyloid P component (see amyloid)
- Serum amyloid A
- Prealbumin
Serum albumin concentrations fall in acute disease states. For this reason albumin is sometimes referred to as a negative acute phase protein.
Clinical significance
Measurement of acute phase proteins is a useful marker of inflammation in both medical and veterinary clinical pathology. It correlates with the erythrocyte sedimentation rate (ESR).
External links
Acute phase proteins |
|---|
| Alpha 1-antichymotrypsin - Alpha 1-antitrypsin - Alpha 2-macroglobulin - C-reactive protein - Ceruloplasmin - C3 - Fibrin - Haptoglobin - Haemopexin - Orosomucoid - Serum albumin (negative) - Amyloid (P, A) - Transferrin |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies